name	nAnno	nOverlap	fc	zscore	pvalue	adjp	or	CIl	CIu
R-HSA-8953854	Metabolism of RNA	646	473	1.39	10.9	8.6e-29	1.1e-25	2.61	2.18	3.15
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	243	197	1.54	9.02	5.9e-21	3.7e-18	3.98	2.87	5.63
R-HSA-72172	mRNA Splicing	191	156	1.55	8.14	2e-17	8.4e-15	4.12	2.83	6.14
R-HSA-1640170	Cell Cycle	607	417	1.31	8.22	5.4e-17	1.7e-14	2.07	1.73	2.48
R-HSA-392499	Metabolism of proteins	1907	1162	1.16	8.16	1.6e-16	3.9e-14	1.52	1.38	1.69
R-HSA-72163	mRNA Splicing - Major Pathway	183	149	1.55	7.9	1.8e-16	3.9e-14	4.04	2.76	6.07
R-HSA-69278	Cell Cycle, Mitotic	531	359	1.29	7.14	3.3e-13	6e-11	1.95	1.61	2.36
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	310	224	1.38	7.06	4.6e-13	7.1e-11	2.41	1.87	3.14
R-HSA-73894	DNA Repair	315	227	1.37	7.05	5e-13	7.1e-11	2.39	1.85	3.1
R-HSA-597592	Post-translational protein modification	1353	830	1.17	6.97	1.5e-12	1.9e-10	1.51	1.35	1.71
R-HSA-199991	Membrane Trafficking	599	396	1.26	6.86	2.9e-12	3.3e-10	1.82	1.53	2.18
R-HSA-1852241	Organelle biogenesis and maintenance	269	195	1.38	6.64	9.5e-12	1e-09	2.43	1.85	3.23
R-HSA-5663202	Diseases of signal transduction	359	250	1.33	6.61	1.4e-11	1.4e-09	2.12	1.68	2.7
R-HSA-983169	Class I MHC mediated antigen processing & presentation	365	252	1.31	6.43	4.9e-11	4.5e-09	2.07	1.64	2.61
R-HSA-3700989	Transcriptional Regulation by TP53	365	250	1.3	6.22	2.1e-10	1.8e-08	2.01	1.6	2.54
R-HSA-5653656	Vesicle-mediated transport	631	407	1.23	6.21	2.4e-10	1.9e-08	1.69	1.43	2.01
R-HSA-1643685	Disease	984	608	1.18	6.12	4.8e-10	3.6e-08	1.52	1.33	1.75
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	84	71	1.61	5.89	6e-10	4.2e-08	4.99	2.73	9.83
R-HSA-5368287	Mitochondrial translation	87	73	1.6	5.88	6.8e-10	4.6e-08	4.76	2.66	9.15
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	83	70	1.61	5.82	9.7e-10	6.2e-08	4.92	2.69	9.7
R-HSA-5696398	Nucleotide Excision Repair	111	89	1.53	5.86	1.1e-09	6.3e-08	3.7	2.29	6.21
R-HSA-5419276	Mitochondrial translation termination	86	72	1.59	5.82	1.1e-09	6.3e-08	4.7	2.62	9.03
R-HSA-72187	mRNA 3'-end processing	58	52	1.71	5.68	1.4e-09	7.8e-08	7.9	3.39	22.5
R-HSA-3371556	Cellular response to heat stress	88	73	1.58	5.74	1.9e-09	1e-07	4.44	2.52	8.35
R-HSA-8953897	Cellular responses to external stimuli	493	322	1.24	5.82	2.7e-09	1.4e-07	1.75	1.44	2.12
R-HSA-5389840	Mitochondrial translation elongation	84	70	1.59	5.68	2.8e-09	1.4e-07	4.56	2.54	8.78
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	74	63	1.62	5.64	3.1e-09	1.5e-07	5.22	2.73	11
R-HSA-1430728	Metabolism	1899	1111	1.11	5.78	4e-09	1.7e-07	1.35	1.22	1.49
R-HSA-6807070	PTEN Regulation	140	107	1.45	5.7	3.9e-09	1.7e-07	2.97	1.99	4.54
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	76	64	1.6	5.55	5.8e-09	2.5e-07	4.86	2.6	9.91
R-HSA-2990846	SUMOylation	127	98	1.47	5.59	7.3e-09	3e-07	3.09	2.02	4.86
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	121	94	1.48	5.57	8e-09	3.2e-07	3.18	2.05	5.09
R-HSA-72766	Translation	258	180	1.33	5.61	8.7e-09	3.3e-07	2.12	1.61	2.81
R-HSA-5663205	Infectious disease	326	220	1.28	5.49	1.9e-08	6.6e-07	1.91	1.5	2.44
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region 	67	57	1.62	5.35	1.9e-08	6.6e-07	5.19	2.62	11.4
R-HSA-73856	RNA Polymerase II Transcription Termination	67	57	1.62	5.35	1.9e-08	6.6e-07	5.19	2.62	11.4
R-HSA-556833	Metabolism of lipids	696	434	1.19	5.38	4e-08	1.4e-06	1.54	1.31	1.81
R-HSA-5617833	Cilium Assembly	201	143	1.35	5.34	4.2e-08	1.4e-06	2.26	1.65	3.13
R-HSA-9006925	Intracellular signaling by second messengers	282	192	1.3	5.3	5.5e-08	1.8e-06	1.96	1.51	2.56
R-HSA-1257604	PIP3 activates AKT signaling	254	175	1.31	5.29	5.9e-08	1.9e-06	2.04	1.55	2.7
R-HSA-446203	Asparagine N-linked glycosylation	299	202	1.29	5.28	6.3e-08	1.9e-06	1.92	1.49	2.48
R-HSA-162906	HIV Infection	184	132	1.37	5.26	6.3e-08	1.9e-06	2.33	1.67	3.28
R-HSA-68886	M Phase	391	256	1.25	5.22	8.9e-08	2.6e-06	1.75	1.41	2.18
R-HSA-9006934	Signaling by Receptor Tyrosine Kinases	487	311	1.22	5.13	1.5e-07	4.4e-06	1.63	1.35	1.99
R-HSA-69242	S Phase	138	102	1.41	5.06	1.8e-07	5.1e-06	2.59	1.75	3.91
R-HSA-8868773	rRNA processing in the nucleus and cytosol	191	135	1.35	5.07	1.9e-07	5.2e-06	2.21	1.6	3.08
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	51	44	1.64	4.84	3.6e-07	9.5e-06	5.72	2.55	15.1
R-HSA-2980766	Nuclear Envelope Breakdown	51	44	1.64	4.84	3.6e-07	9.5e-06	5.72	2.55	15.1
R-HSA-5633007	Regulation of TP53 Activity	160	115	1.37	4.94	3.7e-07	9.7e-06	2.34	1.64	3.38
R-HSA-69620	Cell Cycle Checkpoints	292	195	1.27	4.95	3.9e-07	9.9e-06	1.85	1.44	2.39
R-HSA-2262752	Cellular responses to stress	425	273	1.22	4.93	4.3e-07	1.1e-05	1.66	1.35	2.04
R-HSA-72312	rRNA processing	201	140	1.33	4.91	4.6e-07	1.1e-05	2.1	1.54	2.9
R-HSA-69275	G2/M Transition	195	136	1.33	4.86	5.9e-07	1.4e-05	2.11	1.54	2.92
R-HSA-453274	Mitotic G2-G2/M phases	197	137	1.32	4.83	7e-07	1.6e-05	2.09	1.53	2.89
R-HSA-4570464	SUMOylation of RNA binding proteins	46	40	1.66	4.68	8e-07	1.8e-05	6.06	2.55	17.5
R-HSA-68877	Mitotic Prometaphase	199	138	1.32	4.8	8.2e-07	1.9e-05	2.07	1.52	2.86
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	68	55	1.54	4.7	1e-06	2.3e-05	3.85	2.07	7.69
R-HSA-6791226	Major pathway of rRNA processing in the nucleolus and cytosol	182	127	1.33	4.7	1.3e-06	2.9e-05	2.11	1.52	2.96
R-HSA-8856828	Clathrin-mediated endocytosis	140	101	1.37	4.68	1.4e-06	3.1e-05	2.37	1.62	3.52
R-HSA-68882	Mitotic Anaphase	202	139	1.31	4.68	1.5e-06	3.2e-05	2.02	1.49	2.77
R-HSA-381119	Unfolded Protein Response (UPR)	93	71	1.45	4.62	1.8e-06	3.7e-05	2.94	1.8	4.99
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	87	67	1.47	4.59	2e-06	4.1e-05	3.05	1.83	5.32
R-HSA-162587	HIV Life Cycle	101	76	1.43	4.59	2.1e-06	4.2e-05	2.77	1.74	4.55
R-HSA-162909	Host Interactions of HIV factors	128	93	1.38	4.59	2.2e-06	4.4e-05	2.42	1.62	3.69
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	120	88	1.4	4.59	2.2e-06	4.4e-05	2.51	1.65	3.89
R-HSA-2555396	Mitotic Metaphase and Anaphase	203	139	1.3	4.59	2.3e-06	4.5e-05	1.99	1.46	2.72
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	47	40	1.62	4.48	2.6e-06	5e-05	5.19	2.3	13.8
R-HSA-453279	Mitotic G1-G1/S phases	143	102	1.36	4.53	3e-06	5.6e-05	2.27	1.56	3.36
R-HSA-5358351	Signaling by Hedgehog	148	105	1.35	4.52	3.2e-06	5.9e-05	2.23	1.55	3.27
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	97	73	1.43	4.5	3.3e-06	5.9e-05	2.77	1.72	4.61
R-HSA-69206	G1/S Transition	124	90	1.38	4.5	3.5e-06	6.3e-05	2.41	1.61	3.7
R-HSA-4615885	SUMOylation of DNA replication proteins	43	37	1.64	4.41	3.7e-06	6.4e-05	5.6	2.34	16.3
R-HSA-5696395	Formation of Incision Complex in GG-NER	43	37	1.64	4.41	3.7e-06	6.4e-05	5.6	2.34	16.3
R-HSA-8951664	Neddylation	235	157	1.27	4.43	5.1e-06	8.7e-05	1.84	1.39	2.46
R-HSA-5683057	MAPK family signaling cascades	288	188	1.24	4.39	6.2e-06	1e-04	1.72	1.34	2.23
R-HSA-1989781	PPARA activates gene expression	117	85	1.38	4.38	6.1e-06	1e-04	2.42	1.59	3.77
R-HSA-73762	RNA Polymerase I Transcription Initiation	45	38	1.61	4.3	7e-06	0.00012	4.93	2.17	13.1
R-HSA-8854518	AURKA Activation by TPX2	72	56	1.48	4.3	8.1e-06	0.00013	3.18	1.8	5.96
R-HSA-380259	Loss of Nlp from mitotic centrosomes	69	54	1.49	4.29	8.5e-06	0.00013	3.27	1.82	6.26
R-HSA-380284	Loss of proteins required for interphase microtubule organization from the centrosome	69	54	1.49	4.29	8.5e-06	0.00013	3.27	1.82	6.26
R-HSA-8939243	RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known	38	33	1.65	4.24	8.3e-06	0.00013	5.99	2.32	19.7
R-HSA-399719	Trafficking of AMPA receptors	31	28	1.72	4.22	7.8e-06	0.00013	8.47	2.61	43.6
R-HSA-399721	Glutamate binding, activation of AMPA receptors and synaptic plasticity	31	28	1.72	4.22	7.8e-06	0.00013	8.47	2.61	43.6
R-HSA-166520	Signalling by NGF	147	103	1.33	4.29	9.8e-06	0.00015	2.14	1.48	3.12
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	41	35	1.62	4.22	9.9e-06	0.00015	5.3	2.2	15.4
R-HSA-5632684	Hedgehog 'on' state	85	64	1.43	4.22	1.3e-05	0.00019	2.77	1.67	4.79
R-HSA-69618	Mitotic Spindle Checkpoint	112	81	1.38	4.22	1.3e-05	2e-04	2.38	1.55	3.73
R-HSA-6784531	tRNA processing in the nucleus	56	45	1.53	4.18	1.4e-05	2e-04	3.72	1.89	7.98
R-HSA-6802957	Oncogenic MAPK signaling	76	58	1.45	4.17	1.6e-05	0.00023	2.93	1.7	5.3
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	40	34	1.62	4.12	1.6e-05	0.00023	5.14	2.13	15
R-HSA-5684996	MAPK1/MAPK3 signaling	249	163	1.25	4.13	2e-05	0.00028	1.73	1.32	2.29
R-HSA-6804756	Regulation of TP53 Activity through Phosphorylation	92	68	1.41	4.12	2e-05	0.00028	2.58	1.6	4.3
R-HSA-191859	snRNP Assembly	52	42	1.54	4.09	2.1e-05	0.00029	3.82	1.88	8.54
R-HSA-194441	Metabolism of non-coding RNA	52	42	1.54	4.09	2.1e-05	0.00029	3.82	1.88	8.54
R-HSA-400253	Circadian Clock	36	31	1.64	4.04	2.3e-05	0.00031	5.63	2.17	18.5
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	86	64	1.42	4.08	2.4e-05	0.00032	2.65	1.61	4.52
R-HSA-453276	Regulation of mitotic cell cycle	86	64	1.42	4.08	2.4e-05	0.00032	2.65	1.61	4.52
R-HSA-5673001	RAF/MAP kinase cascade	243	159	1.25	4.07	2.6e-05	0.00034	1.73	1.32	2.29
R-HSA-4551638	SUMOylation of chromatin organization proteins	69	53	1.46	4.05	2.7e-05	0.00034	3.01	1.69	5.65
R-HSA-168276	NS1 Mediated Effects on Host Pathways	39	33	1.61	4.02	2.7e-05	0.00034	4.99	2.06	14.6
R-HSA-3928662	EPHB-mediated forward signaling	39	33	1.61	4.02	2.7e-05	0.00034	4.99	2.06	14.6
R-HSA-191273	Cholesterol biosynthesis	25	23	1.75	3.96	2.7e-05	0.00034	10.4	2.57	91.3
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	80	60	1.43	4.04	2.9e-05	0.00036	2.73	1.62	4.79
R-HSA-2467813	Separation of Sister Chromatids	191	128	1.28	4.04	3e-05	0.00036	1.86	1.36	2.56
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	42	35	1.59	4	2.9e-05	0.00036	4.54	1.98	12.1
R-HSA-162599	Late Phase of HIV Life Cycle	88	65	1.41	4.02	3.2e-05	0.00037	2.57	1.57	4.34
R-HSA-6802952	Signaling by BRAF and RAF fusions	60	47	1.49	4.01	3.1e-05	0.00037	3.29	1.75	6.63
R-HSA-180910	Vpr-mediated nuclear import of PICs	32	28	1.67	3.97	3.1e-05	0.00037	6.35	2.22	24.9
R-HSA-6807505	RNA polymerase II transcribes snRNA genes	74	56	1.44	4	3.4e-05	4e-04	2.83	1.64	5.12
R-HSA-1169408	ISG15 antiviral mechanism	71	54	1.45	3.98	3.7e-05	0.00042	2.89	1.65	5.32
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	71	54	1.45	3.98	3.7e-05	0.00042	2.89	1.65	5.32
R-HSA-176033	Interactions of Vpr with host cellular proteins	35	30	1.63	3.94	3.8e-05	0.00042	5.44	2.09	18
R-HSA-177243	Interactions of Rev with host cellular proteins	35	30	1.63	3.94	3.8e-05	0.00042	5.44	2.09	18
R-HSA-8953750	Transcriptional Regulation by E2F6	35	30	1.63	3.94	3.8e-05	0.00042	5.44	2.09	18
R-HSA-1592230	Mitochondrial biogenesis	68	52	1.46	3.96	4e-05	0.00044	2.95	1.66	5.55
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	79	59	1.42	3.96	4.2e-05	0.00046	2.68	1.59	4.71
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	65	50	1.46	3.95	4.2e-05	0.00046	3.03	1.67	5.82
R-HSA-5696394	DNA Damage Recognition in GG-NER	38	32	1.6	3.92	4.3e-05	0.00047	4.84	1.99	14.2
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	76	57	1.43	3.94	4.6e-05	0.00049	2.73	1.6	4.86
R-HSA-168253	Host Interactions with Influenza Factors	41	34	1.58	3.9	4.7e-05	5e-04	4.41	1.92	11.8
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	73	55	1.43	3.92	5e-05	0.00053	2.78	1.6	5.03
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	34	29	1.62	3.83	6.2e-05	0.00065	5.26	2.01	17.4
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	75	56	1.42	3.85	6.6e-05	0.00069	2.68	1.57	4.78
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	72	54	1.43	3.83	7.3e-05	0.00075	2.73	1.57	4.95
R-HSA-429914	Deadenylation-dependent mRNA decay	55	43	1.49	3.82	7.4e-05	0.00076	3.25	1.68	6.79
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	80	59	1.4	3.81	7.8e-05	0.00078	2.55	1.53	4.43
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	80	59	1.4	3.81	7.8e-05	0.00078	2.55	1.53	4.43
R-HSA-380287	Centrosome maturation	80	59	1.4	3.81	7.8e-05	0.00078	2.55	1.53	4.43
R-HSA-5607764	CLEC7A (Dectin-1) signaling	96	69	1.37	3.81	8e-05	0.00079	2.33	1.47	3.78
R-HSA-170834	Signaling by TGF-beta Receptor Complex	66	50	1.44	3.79	8.6e-05	0.00084	2.84	1.59	5.35
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	30	26	1.65	3.75	8.7e-05	0.00084	5.89	2.04	23.3
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	30	26	1.65	3.75	8.7e-05	0.00084	5.89	2.04	23.3
R-HSA-77595	Processing of Intronless Pre-mRNAs	19	18	1.8	3.69	8.8e-05	0.00084	16.3	2.57	678
R-HSA-159227	Transport of the SLBP independent Mature mRNA	33	28	1.61	3.72	1e-04	0.00096	5.08	1.93	16.9
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	33	28	1.61	3.72	1e-04	0.00096	5.08	1.93	16.9
R-HSA-1632852	Macroautophagy	68	51	1.43	3.72	0.00012	0.0011	2.73	1.55	5.04
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	68	51	1.43	3.72	0.00012	0.0011	2.73	1.55	5.04
R-HSA-75153	Apoptotic execution  phase	51	40	1.49	3.71	0.00012	0.0011	3.3	1.66	7.14
R-HSA-168325	Viral Messenger RNA Synthesis	42	34	1.54	3.69	0.00012	0.0011	3.86	1.75	9.66
R-HSA-2682334	EPH-Ephrin signaling	81	59	1.39	3.67	0.00014	0.0013	2.44	1.47	4.19
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	81	59	1.39	3.67	0.00014	0.0013	2.44	1.47	4.19
R-HSA-199977	ER to Golgi Anterograde Transport	155	104	1.28	3.66	0.00015	0.0013	1.86	1.31	2.66
R-HSA-381070	IRE1alpha activates chaperones	59	45	1.45	3.66	0.00015	0.0013	2.92	1.57	5.77
R-HSA-5693532	DNA Double-Strand Break Repair	165	110	1.27	3.66	0.00015	0.0013	1.82	1.3	2.58
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	29	25	1.64	3.64	0.00015	0.0013	5.67	1.95	22.4
R-HSA-69239	Synthesis of DNA	99	70	1.35	3.64	0.00016	0.0014	2.2	1.4	3.52
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	67	50	1.42	3.63	0.00017	0.0014	2.67	1.51	4.95
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	32	27	1.61	3.61	0.00017	0.0014	4.9	1.86	16.3
R-HSA-1362277	Transcription of E2F targets under negative control by DREAM complex	18	17	1.8	3.56	0.00016	0.0014	15.4	2.41	642
R-HSA-73776	RNA Polymerase II Promoter Escape	47	37	1.5	3.6	0.00018	0.0015	3.36	1.64	7.58
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	47	37	1.5	3.6	0.00018	0.0015	3.36	1.64	7.58
R-HSA-75953	RNA Polymerase II Transcription Initiation	47	37	1.5	3.6	0.00018	0.0015	3.36	1.64	7.58
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	47	37	1.5	3.6	0.00018	0.0015	3.36	1.64	7.58
R-HSA-15869	Metabolism of nucleotides	101	71	1.34	3.59	2e-04	0.0016	2.15	1.38	3.42
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	72	53	1.4	3.59	2e-04	0.0016	2.53	1.47	4.54
R-HSA-70171	Glycolysis	61	46	1.44	3.59	2e-04	0.0016	2.79	1.52	5.38
R-HSA-8943724	Regulation of PTEN gene transcription	61	46	1.44	3.59	2e-04	0.0016	2.79	1.52	5.38
R-HSA-8948751	Regulation of PTEN stability and activity	69	51	1.41	3.57	0.00022	0.0017	2.57	1.48	4.69
R-HSA-6811442	Intra-Golgi and retrograde Golgi-to-ER traffic	200	130	1.24	3.56	0.00021	0.0017	1.69	1.25	2.31
R-HSA-6782135	Dual incision in TC-NER	66	49	1.41	3.54	0.00024	0.0019	2.62	1.48	4.86
R-HSA-69306	DNA Replication	108	75	1.32	3.54	0.00024	0.0019	2.07	1.35	3.22
R-HSA-8878159	Transcriptional regulation by RUNX3	108	75	1.32	3.54	0.00024	0.0019	2.07	1.35	3.22
R-HSA-69202	Cyclin E associated events during G1/S transition 	82	59	1.37	3.53	0.00025	0.0019	2.33	1.42	3.96
R-HSA-72165	mRNA Splicing - Minor Pathway	52	40	1.46	3.53	0.00025	0.0019	3.03	1.55	6.34
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	63	47	1.42	3.52	0.00026	0.002	2.67	1.48	5.05
R-HSA-445144	Signal transduction by L1	21	19	1.72	3.48	0.00026	0.002	8.61	2.07	76.2
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	34	28	1.57	3.49	0.00029	0.0022	4.23	1.72	12.5
R-HSA-176187	Activation of ATR in response to replication stress	37	30	1.54	3.48	3e-04	0.0022	3.89	1.67	10.5
R-HSA-5674135	MAP2K and MAPK activation	40	32	1.52	3.48	3e-04	0.0022	3.63	1.64	9.12
R-HSA-6783310	Fanconi Anemia Pathway	40	32	1.52	3.48	3e-04	0.0022	3.63	1.64	9.12
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	17	16	1.79	3.44	0.00029	0.0022	14.5	2.25	606
R-HSA-8934593	Regulation of RUNX1 Expression and Activity	17	16	1.79	3.44	0.00029	0.0022	14.5	2.25	606
R-HSA-381038	XBP1(S) activates chaperone genes	57	43	1.44	3.47	0.00032	0.0023	2.79	1.49	5.53
R-HSA-948021	Transport to the Golgi and subsequent modification	186	121	1.24	3.45	0.00033	0.0024	1.7	1.24	2.34
R-HSA-195253	Degradation of beta-catenin by the destruction complex	81	58	1.36	3.45	0.00034	0.0025	2.29	1.39	3.9
R-HSA-168254	Influenza Infection	154	102	1.26	3.43	0.00036	0.0026	1.79	1.26	2.55
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	86	61	1.35	3.43	0.00037	0.0027	2.22	1.37	3.69
R-HSA-141424	Amplification of signal from the kinetochores	96	67	1.33	3.4	0.00041	0.0029	2.1	1.34	3.38
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	96	67	1.33	3.4	0.00041	0.0029	2.1	1.34	3.38
R-HSA-72306	tRNA processing	83	59	1.35	3.4	0.00042	0.003	2.23	1.37	3.76
R-HSA-5685942	HDR through Homologous Recombination (HRR)	67	49	1.39	3.39	0.00044	0.0031	2.47	1.41	4.52
R-HSA-73884	Base Excision Repair	39	31	1.51	3.38	0.00046	0.0031	3.51	1.58	8.86
R-HSA-73933	Resolution of Abasic Sites (AP sites)	39	31	1.51	3.38	0.00046	0.0031	3.51	1.58	8.86
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	20	18	1.71	3.36	0.00044	0.0031	8.15	1.95	72.3
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	20	18	1.71	3.36	0.00044	0.0031	8.15	1.95	72.3
R-HSA-3371511	HSF1 activation	12	12	1.9	3.29	0.00044	0.0031	Inf	2.51	Inf
R-HSA-6802949	Signaling by RAS mutants	53	40	1.44	3.35	5e-04	0.0034	2.79	1.46	5.7
R-HSA-68874	M/G1 Transition	85	60	1.34	3.35	0.00051	0.0034	2.18	1.34	3.64
R-HSA-69002	DNA Replication Pre-Initiation	85	60	1.34	3.35	0.00051	0.0034	2.18	1.34	3.64
R-HSA-109581	Apoptosis	108	74	1.3	3.34	0.00051	0.0034	1.98	1.3	3.07
R-HSA-5610787	Hedgehog 'off' state	113	77	1.3	3.34	0.00051	0.0034	1.95	1.29	2.98
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	108	74	1.3	3.34	0.00051	0.0034	1.98	1.3	3.07
R-HSA-69481	G2/M Checkpoints	167	109	1.24	3.32	0.00053	0.0035	1.71	1.23	2.4
R-HSA-8856825	Cargo recognition for clathrin-mediated endocytosis	100	69	1.31	3.31	0.00057	0.0037	2.02	1.3	3.21
R-HSA-1660661	Sphingolipid de novo biosynthesis	44	34	1.47	3.29	0.00063	0.0041	3.08	1.49	7.01
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	26	22	1.61	3.28	0.00065	0.0042	4.98	1.69	19.9
R-HSA-901042	Calnexin/calreticulin cycle	26	22	1.61	3.28	0.00065	0.0042	4.98	1.69	19.9
R-HSA-5696400	Dual Incision in GG-NER	41	32	1.49	3.28	0.00067	0.0043	3.22	1.5	7.69
R-HSA-111465	Apoptotic cleavage of cellular proteins	38	30	1.5	3.27	7e-04	0.0045	3.4	1.52	8.59
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	35	28	1.52	3.26	0.00072	0.0046	3.63	1.55	9.85
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	19	17	1.7	3.23	0.00076	0.0048	7.7	1.83	68.8
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	60	44	1.4	3.23	0.00077	0.0049	2.5	1.38	4.75
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	57	42	1.4	3.21	0.00086	0.0053	2.54	1.38	4.94
R-HSA-4641258	Degradation of DVL	57	42	1.4	3.21	0.00086	0.0053	2.54	1.38	4.94
R-HSA-5610780	Degradation of GLI1 by the proteasome	57	42	1.4	3.21	0.00086	0.0053	2.54	1.38	4.94
R-HSA-69300	Removal of licensing factors from origins	73	52	1.36	3.21	0.00084	0.0053	2.25	1.33	3.94
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	126	84	1.27	3.2	0.00085	0.0053	1.82	1.24	2.71
R-HSA-168255	Influenza Life Cycle	143	94	1.25	3.18	0.00089	0.0054	1.75	1.22	2.53
R-HSA-194840	Rho GTPase cycle	138	91	1.26	3.17	0.00091	0.0056	1.76	1.22	2.57
R-HSA-5099900	WNT5A-dependent internalization of FZD4	15	14	1.78	3.17	0.00093	0.0056	12.7	1.93	535
R-HSA-5358508	Mismatch Repair	15	14	1.78	3.17	0.00093	0.0056	12.7	1.93	535
R-HSA-165159	mTOR signalling	40	31	1.48	3.17	0.001	0.006	3.12	1.45	7.47
R-HSA-6802946	Signaling by moderate kinase activity BRAF mutants	40	31	1.48	3.17	0.001	0.006	3.12	1.45	7.47
R-HSA-6802955	Paradoxical activation of RAF signaling by kinase inactive BRAF	40	31	1.48	3.17	0.001	0.006	3.12	1.45	7.47
R-HSA-1483257	Phospholipid metabolism	200	127	1.21	3.13	0.001	0.006	1.59	1.18	2.15
R-HSA-1538133	G0 and Early G1	25	21	1.6	3.15	0.0011	0.0062	4.76	1.6	19.1
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	25	21	1.6	3.15	0.0011	0.0062	4.76	1.6	19.1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	31	25	1.53	3.14	0.0011	0.0064	3.78	1.51	11.3
R-HSA-499943	Interconversion of nucleotide di- and triphosphates	31	25	1.53	3.14	0.0011	0.0064	3.78	1.51	11.3
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	59	43	1.39	3.14	0.0011	0.0064	2.44	1.34	4.64
R-HSA-73863	RNA Polymerase I Transcription Termination	31	25	1.53	3.14	0.0011	0.0064	3.78	1.51	11.3
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	28	23	1.56	3.14	0.0011	0.0064	4.17	1.55	14
R-HSA-8939902	Regulation of RUNX2 expression and activity	59	43	1.39	3.14	0.0011	0.0064	2.44	1.34	4.64
R-HSA-5357801	Programmed Cell Death	115	77	1.27	3.11	0.0011	0.0065	1.84	1.23	2.8
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	56	41	1.39	3.11	0.0012	0.0069	2.48	1.34	4.83
R-HSA-1280218	Adaptive Immune System	746	432	1.1	3.05	0.0013	0.0071	1.26	1.08	1.48
R-HSA-1839117	Signaling by cytosolic FGFR1 fusion mutants	18	16	1.69	3.09	0.0013	0.0074	7.24	1.7	65
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	42	32	1.45	3.08	0.0014	0.0078	2.9	1.39	6.62
R-HSA-1169091	Activation of NF-kappaB in B cells	66	47	1.36	3.05	0.0015	0.0082	2.25	1.29	4.06
R-HSA-674695	RNA Polymerase II Pre-transcription Events	84	58	1.31	3.04	0.0015	0.0082	2.03	1.25	3.36
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	58	42	1.38	3.04	0.0015	0.0083	2.38	1.31	4.54
R-HSA-2644603	Signaling by NOTCH1 in Cancer	58	42	1.38	3.04	0.0015	0.0083	2.38	1.31	4.54
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	58	42	1.38	3.04	0.0015	0.0083	2.38	1.31	4.54
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	58	42	1.38	3.04	0.0015	0.0083	2.38	1.31	4.54
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	58	42	1.38	3.04	0.0015	0.0083	2.38	1.31	4.54
R-HSA-4086400	PCP/CE pathway	89	61	1.3	3.04	0.0015	0.0083	1.98	1.24	3.22
R-HSA-901032	ER Quality Control Compartment (ERQC)	21	18	1.63	3.05	0.0016	0.0084	5.43	1.58	28.8
R-HSA-68949	Orc1 removal from chromatin	71	50	1.34	3.03	0.0016	0.0084	2.16	1.27	3.79
R-HSA-69052	Switching of origins to a post-replicative state	71	50	1.34	3.03	0.0016	0.0084	2.16	1.27	3.79
R-HSA-6802948	Signaling by high-kinase activity BRAF mutants	36	28	1.48	3.04	0.0016	0.0085	3.17	1.41	8.06
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	14	13	1.77	3.02	0.0017	0.0087	11.8	1.77	499
R-HSA-69304	Regulation of DNA replication	76	53	1.33	3.01	0.0017	0.0087	2.09	1.26	3.58
R-HSA-3371571	HSF1-dependent transactivation	24	20	1.59	3.02	0.0017	0.0088	4.53	1.52	18.2
R-HSA-75105	Fatty acyl-CoA biosynthesis	33	26	1.5	3.02	0.0017	0.0088	3.37	1.42	9.19
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	81	56	1.32	3	0.0017	0.0088	2.03	1.25	3.41
R-HSA-70326	Glucose metabolism	81	56	1.32	3	0.0017	0.0088	2.03	1.25	3.41
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	30	24	1.52	3.02	0.0017	0.0089	3.62	1.44	10.9
R-HSA-73772	RNA Polymerase I Promoter Escape	30	24	1.52	3.02	0.0017	0.0089	3.62	1.44	10.9
R-HSA-4641257	Degradation of AXIN	55	40	1.38	3.01	0.0017	0.0089	2.42	1.31	4.72
R-HSA-8941858	Regulation of RUNX3 expression and activity	55	40	1.38	3.01	0.0017	0.0089	2.42	1.31	4.72
R-HSA-5688426	Deubiquitination	295	180	1.16	2.96	0.0018	0.009	1.43	1.12	1.83
R-HSA-194315	Signaling by Rho GTPases	441	262	1.13	2.95	0.0018	0.009	1.34	1.1	1.64
R-HSA-68867	Assembly of the pre-replicative complex	68	48	1.34	2.99	0.0018	0.0091	2.18	1.27	3.88
R-HSA-9007101	Rab regulation of trafficking	123	81	1.25	2.97	0.0018	0.0091	1.75	1.19	2.62
R-HSA-194138	Signaling by VEGF	103	69	1.27	2.95	0.002	0.0099	1.84	1.2	2.87
R-HSA-157118	Signaling by NOTCH	65	46	1.35	2.95	0.0021	0.01	2.2	1.26	3.98
R-HSA-5693538	Homology Directed Repair	137	89	1.24	2.93	0.0021	0.01	1.69	1.17	2.45
R-HSA-1227986	Signaling by ERBB2	49	36	1.4	2.94	0.0022	0.011	2.51	1.3	5.17
R-HSA-5655302	Signaling by FGFR1 in disease	38	29	1.45	2.94	0.0022	0.011	2.92	1.34	7.02
R-HSA-73893	DNA Damage Bypass	49	36	1.4	2.94	0.0022	0.011	2.51	1.3	5.17
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	75	52	1.32	2.92	0.0022	0.011	2.05	1.23	3.52
R-HSA-2262749	Cellular response to hypoxia	75	52	1.32	2.92	0.0022	0.011	2.05	1.23	3.52
R-HSA-2028269	Signaling by Hippo	20	17	1.62	2.91	0.0026	0.012	5.13	1.48	27.3
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	67	47	1.34	2.9	0.0025	0.012	2.13	1.24	3.81
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	54	39	1.37	2.9	0.0024	0.012	2.36	1.27	4.61
R-HSA-199992	trans-Golgi Network Vesicle Budding	72	50	1.32	2.88	0.0026	0.012	2.06	1.22	3.58
R-HSA-421837	Clathrin derived vesicle budding	72	50	1.32	2.88	0.0026	0.012	2.06	1.22	3.58
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	72	50	1.32	2.88	0.0026	0.012	2.06	1.22	3.58
R-HSA-5387390	Hh mutants abrogate ligand secretion	59	42	1.35	2.88	0.0027	0.012	2.24	1.25	4.21
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	59	42	1.35	2.88	0.0027	0.012	2.24	1.25	4.21
R-HSA-9020702	Interleukin-1 signaling	102	68	1.27	2.87	0.0026	0.012	1.82	1.18	2.83
R-HSA-5205647	Mitophagy	29	23	1.51	2.89	0.0027	0.013	3.47	1.37	10.4
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	51	37	1.38	2.87	0.0028	0.013	2.4	1.26	4.81
R-HSA-5620920	Cargo trafficking to the periciliary membrane	51	37	1.38	2.87	0.0028	0.013	2.4	1.26	4.81
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	13	12	1.76	2.87	0.0029	0.014	10.9	1.61	463
R-HSA-2995410	Nuclear Envelope Reassembly	13	12	1.76	2.87	0.0029	0.014	10.9	1.61	463
R-HSA-432722	Golgi Associated Vesicle Biogenesis	56	40	1.36	2.84	0.003	0.014	2.27	1.24	4.34
R-HSA-168273	Influenza Viral RNA Transcription and Replication	133	86	1.23	2.82	0.003	0.014	1.66	1.15	2.43
R-HSA-5687128	MAPK6/MAPK4 signaling	89	60	1.28	2.82	0.003	0.014	1.88	1.18	3.04
R-HSA-5678895	Defective CFTR causes cystic fibrosis	61	43	1.34	2.82	0.0032	0.015	2.17	1.22	4
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	37	28	1.44	2.82	0.0033	0.015	2.82	1.29	6.8
R-HSA-4791275	Signaling by WNT in cancer	34	26	1.46	2.8	0.0036	0.016	2.94	1.29	7.53
R-HSA-5628897	TP53 Regulates Metabolic Genes	86	58	1.28	2.78	0.0035	0.016	1.88	1.18	3.07
R-HSA-3858494	Beta-catenin independent WNT signaling	137	88	1.22	2.76	0.0035	0.016	1.63	1.14	2.37
R-HSA-3000170	Syndecan interactions	16	14	1.67	2.8	0.0038	0.017	6.34	1.45	57.4
R-HSA-1839124	FGFR1 mutant receptor activation	31	24	1.47	2.78	0.0039	0.017	3.11	1.3	8.54
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	42	31	1.4	2.77	0.0039	0.017	2.55	1.25	5.64
R-HSA-5658442	Regulation of RAS by GAPs	68	47	1.32	2.75	0.0039	0.017	2.03	1.19	3.58
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	93	62	1.27	2.74	0.0039	0.017	1.82	1.16	2.9
R-HSA-422475	Axon guidance	295	178	1.15	2.72	0.0038	0.017	1.39	1.09	1.77
R-HSA-176412	Phosphorylation of the APC/C	19	16	1.6	2.77	0.0042	0.018	4.83	1.38	25.9
R-HSA-3928664	Ephrin signaling	19	16	1.6	2.77	0.0042	0.018	4.83	1.38	25.9
R-HSA-8876725	Protein methylation	19	16	1.6	2.77	0.0042	0.018	4.83	1.38	25.9
R-HSA-381042	PERK regulates gene expression	28	22	1.5	2.76	0.0041	0.018	3.32	1.3	10
R-HSA-1368082	RORA activates gene expression	22	18	1.56	2.75	0.0044	0.018	4.07	1.34	16.6
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	22	18	1.56	2.75	0.0044	0.018	4.07	1.34	16.6
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	25	20	1.52	2.75	0.0043	0.018	3.62	1.32	12.4
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	55	39	1.35	2.74	0.0042	0.018	2.21	1.21	4.24
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	39	29	1.42	2.73	0.0044	0.018	2.63	1.24	6.05
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	60	42	1.33	2.72	0.0044	0.018	2.12	1.19	3.91
R-HSA-8856688	Golgi-to-ER retrograde transport	134	86	1.22	2.72	0.0041	0.018	1.63	1.13	2.37
R-HSA-4420097	VEGFA-VEGFR2 Pathway	95	63	1.26	2.7	0.0044	0.018	1.79	1.15	2.83
R-HSA-5663220	RHO GTPases Activate Formins	141	90	1.21	2.7	0.0042	0.018	1.6	1.12	2.31
R-HSA-9006936	Signaling by TGF-beta family members	95	63	1.26	2.7	0.0044	0.018	1.79	1.15	2.83
R-HSA-193704	p75 NTR receptor-mediated signalling	90	60	1.27	2.7	0.0045	0.019	1.82	1.15	2.92
R-HSA-428157	Sphingolipid metabolism	90	60	1.27	2.7	0.0045	0.019	1.82	1.15	2.92
R-HSA-6794362	Protein-protein interactions at synapses	70	48	1.31	2.7	0.0046	0.019	1.98	1.17	3.45
R-HSA-8876198	RAB GEFs exchange GTP for GDP on RABs	90	60	1.27	2.7	0.0045	0.019	1.82	1.15	2.92
R-HSA-180534	Vpu mediated degradation of CD4	52	37	1.35	2.69	0.0048	0.019	2.24	1.2	4.39
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	52	37	1.35	2.69	0.0048	0.019	2.24	1.2	4.39
R-HSA-69610	p53-Independent DNA Damage Response	52	37	1.35	2.69	0.0048	0.019	2.24	1.2	4.39
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	52	37	1.35	2.69	0.0048	0.019	2.24	1.2	4.39
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	131	84	1.22	2.67	0.0046	0.019	1.62	1.12	2.38
R-HSA-446652	Interleukin-1 family signaling	138	88	1.21	2.66	0.0048	0.019	1.6	1.12	2.32
R-HSA-6811438	Intra-Golgi traffic	44	32	1.38	2.69	0.005	0.02	2.42	1.21	5.16
R-HSA-69541	Stabilization of p53	57	40	1.34	2.67	0.005	0.02	2.13	1.18	4.02
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	12	11	1.74	2.72	0.0052	0.021	9.95	1.45	428
R-HSA-4608870	Asymmetric localization of PCP proteins	62	43	1.32	2.66	0.0052	0.021	2.05	1.17	3.74
R-HSA-1912408	Pre-NOTCH Transcription and Translation	30	23	1.46	2.65	0.0058	0.023	2.98	1.23	8.22
R-HSA-6804758	Regulation of TP53 Activity through Acetylation	30	23	1.46	2.65	0.0058	0.023	2.98	1.23	8.22
R-HSA-8866652	Synthesis of active ubiquitin: roles of E1 and E2 enzymes	30	23	1.46	2.65	0.0058	0.023	2.98	1.23	8.22
R-HSA-8848021	Signaling by PTK6	54	38	1.34	2.63	0.0057	0.023	2.15	1.17	4.14
R-HSA-9006927	Signaling by Non-Receptor Tyrosine Kinases	54	38	1.34	2.63	0.0057	0.023	2.15	1.17	4.14
R-HSA-354192	Integrin alphaIIb beta3 signaling	27	21	1.48	2.63	0.0063	0.024	3.17	1.24	9.6
R-HSA-9006921	Integrin signaling	27	21	1.48	2.63	0.0063	0.024	3.17	1.24	9.6
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	74	50	1.29	2.6	0.0061	0.024	1.89	1.14	3.22
R-HSA-2871837	FCERI mediated NF-kB activation	79	53	1.28	2.6	0.006	0.024	1.85	1.13	3.09
R-HSA-5358346	Hedgehog ligand biogenesis	64	44	1.31	2.6	0.0061	0.024	2	1.15	3.58
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	15	13	1.65	2.65	0.0064	0.025	5.88	1.33	53.7
R-HSA-5637810	Constitutive Signaling by EGFRvIII	15	13	1.65	2.65	0.0064	0.025	5.88	1.33	53.7
R-HSA-5637812	Signaling by EGFRvIII in Cancer	15	13	1.65	2.65	0.0064	0.025	5.88	1.33	53.7
R-HSA-8956320	Nucleobase biosynthesis	15	13	1.65	2.65	0.0064	0.025	5.88	1.33	53.7
R-HSA-203927	MicroRNA (miRNA) biogenesis	24	19	1.51	2.62	0.0067	0.025	3.44	1.24	11.8
R-HSA-539107	Activation of E2F1 target genes at G1/S	24	19	1.51	2.62	0.0067	0.025	3.44	1.24	11.8
R-HSA-69205	G1/S-Specific Transcription	24	19	1.51	2.62	0.0067	0.025	3.44	1.24	11.8
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	51	36	1.34	2.59	0.0066	0.025	2.18	1.16	4.28
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	127	81	1.21	2.55	0.0066	0.025	1.6	1.1	2.36
R-HSA-5635838	Activation of SMO	18	15	1.59	2.62	0.0069	0.026	4.53	1.28	24.4
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	21	17	1.54	2.61	0.0069	0.026	3.85	1.25	15.7
R-HSA-6804115	TP53 regulates transcription of additional cell cycle genes whose exact role in the p53 pathway remain uncertain	21	17	1.54	2.61	0.0069	0.026	3.85	1.25	15.7
R-HSA-379724	tRNA Aminoacylation	35	26	1.41	2.58	0.007	0.026	2.62	1.19	6.35
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	61	42	1.31	2.56	0.007	0.026	2	1.14	3.65
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	66	45	1.3	2.55	0.007	0.026	1.94	1.13	3.44
R-HSA-1912422	Pre-NOTCH Expression and Processing	32	24	1.43	2.55	0.0078	0.029	2.72	1.18	7.01
R-HSA-68962	Activation of the pre-replicative complex	32	24	1.43	2.55	0.0078	0.029	2.72	1.18	7.01
R-HSA-177929	Signaling by EGFR	40	29	1.38	2.53	0.0079	0.029	2.39	1.16	5.31
R-HSA-5675221	Negative regulation of MAPK pathway	40	29	1.38	2.53	0.0079	0.029	2.39	1.16	5.31
R-HSA-112315	Transmission across Chemical Synapses	224	136	1.16	2.48	0.0078	0.029	1.41	1.06	1.87
R-HSA-186763	Downstream signal transduction	29	22	1.44	2.52	0.0087	0.031	2.85	1.17	7.9
R-HSA-72086	mRNA Capping	29	22	1.44	2.52	0.0087	0.031	2.85	1.17	7.9
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	11	10	1.73	2.55	0.0092	0.033	9.05	1.29	392
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	11	10	1.73	2.55	0.0092	0.033	9.05	1.29	392
R-HSA-6799198	Complex I biogenesis	55	38	1.31	2.46	0.0092	0.033	2.03	1.11	3.83
R-HSA-6796648	TP53 Regulates Transcription of DNA Repair Genes	65	44	1.29	2.45	0.0093	0.033	1.9	1.1	3.37
R-HSA-382556	ABC-family proteins mediated transport	104	67	1.23	2.44	0.0092	0.033	1.64	1.08	2.53
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	26	20	1.46	2.49	0.0095	0.034	3.02	1.17	9.19
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	23	18	1.49	2.47	0.01	0.036	3.26	1.17	11.2
R-HSA-5627123	RHO GTPases activate PAKs	23	18	1.49	2.47	0.01	0.036	3.26	1.17	11.2
R-HSA-70895	Branched-chain amino acid catabolism	23	18	1.49	2.47	0.01	0.036	3.26	1.17	11.2
R-HSA-5693537	Resolution of D-Loop Structures	34	25	1.4	2.45	0.01	0.036	2.52	1.13	6.13
R-HSA-162594	Early Phase of HIV Life Cycle	14	12	1.63	2.49	0.011	0.037	5.43	1.21	50
R-HSA-3371568	Attenuation phase	14	12	1.63	2.49	0.011	0.037	5.43	1.21	50
R-HSA-8941856	RUNX3 regulates NOTCH signaling	14	12	1.63	2.49	0.011	0.037	5.43	1.21	50
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	52	36	1.32	2.42	0.011	0.037	2.04	1.1	3.94
R-HSA-1268020	Mitochondrial protein import	20	16	1.52	2.46	0.011	0.038	3.62	1.17	14.9
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	17	14	1.57	2.46	0.011	0.038	4.22	1.18	22.9
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	17	14	1.57	2.46	0.011	0.038	4.22	1.18	22.9
R-HSA-5655862	Translesion synthesis by POLK	17	14	1.57	2.46	0.011	0.038	4.22	1.18	22.9
R-HSA-5656121	Translesion synthesis by POLI	17	14	1.57	2.46	0.011	0.038	4.22	1.18	22.9
R-HSA-8949215	Mitochondrial calcium ion transport	17	14	1.57	2.46	0.011	0.038	4.22	1.18	22.9
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	44	31	1.34	2.38	0.012	0.041	2.16	1.1	4.5
R-HSA-6791312	TP53 Regulates Transcription of Cell Cycle Genes	49	34	1.32	2.37	0.012	0.042	2.05	1.09	4.06
R-HSA-8854050	FBXL7 down-regulates AURKA during mitotic entry and in early mitosis	54	37	1.3	2.36	0.012	0.042	1.97	1.08	3.74
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	36	26	1.37	2.37	0.013	0.043	2.35	1.1	5.48
R-HSA-6804757	Regulation of TP53 Degradation	36	26	1.37	2.37	0.013	0.043	2.35	1.1	5.48
R-HSA-380994	ATF4 activates genes	25	19	1.45	2.35	0.014	0.047	2.87	1.1	8.78
R-HSA-429947	Deadenylation of mRNA	25	19	1.45	2.35	0.014	0.047	2.87	1.1	8.78
R-HSA-5673000	RAF activation	25	19	1.45	2.35	0.014	0.047	2.87	1.1	8.78
R-HSA-69273	Cyclin A/B1/B2 associated events during G2/M transition	25	19	1.45	2.35	0.014	0.047	2.87	1.1	8.78
R-HSA-6811440	Retrograde transport at the Trans-Golgi-Network	46	32	1.32	2.32	0.014	0.047	2.07	1.07	4.21
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	51	35	1.31	2.31	0.014	0.047	1.98	1.07	3.84
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	51	35	1.31	2.31	0.014	0.047	1.98	1.07	3.84
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	56	38	1.29	2.3	0.014	0.047	1.91	1.06	3.57
R-HSA-611105	Respiratory electron transport	95	61	1.22	2.29	0.014	0.047	1.63	1.05	2.56
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	33	24	1.38	2.33	0.014	0.048	2.41	1.08	5.91
R-HSA-1483255	PI Metabolism	78	51	1.24	2.28	0.015	0.048	1.71	1.05	2.85
R-HSA-1483206	Glycerophospholipid biosynthesis	123	77	1.19	2.25	0.015	0.05	1.52	1.04	2.24
